News Daily News FDA Approves Bioresorbable Scaffold for BTK Lesions (UPDATED) The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries. Michael O'Riordan April 29, 2024
Presentation Fellows 2024 Peripheral Case Potpourri: Head to Toe (Includes Carotid, Renal, and CLI) Presenter: Sanjum Sethi April 14, 2024
Presentation Fellows 2024 Renal Denervation for Hypertension: What You Need to Know Presenter: Ajay Kirtane April 14, 2024
Presentation Fellows 2024 Workup and Treatment of Lower-Extremity PAD: What All Interventionalists Need to Know Presenter: Sahil Parikh April 14, 2024
Presentation Fellows 2024 Peripheral Skills that Every Interventionalist MUST Learn in Fellowship Presenter: S. Jay Mathews April 14, 2024
Presentation Fellows 2024 Pulmonary Embolism and Venous Disease: The Hottest Frontier of Endovascular Intervention Presenter: Jay Giri April 14, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2024 By Shelley Wood April 30, 2024
News Daily News FDA Approves Bioresorbable Scaffold for BTK Lesions By Michael O'Riordan April 29, 2024
News Daily News BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI By L.A. McKeown April 24, 2024
News Conference News ACC 2024 TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP By L.A. McKeown April 16, 2024
News Conference News ACC 2024 IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease By Caitlin E. Cox April 10, 2024